Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 16,598 |
|
|||||
| News | (1) | ||||||
| Day High | 1.66 | Low High |
|||||
| Day Low | 1.6089 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Sonnet BioTherapeutics Holdings Inc | SONN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.03 | -1.82% | 1.62 | 19:41:44 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.63 | 1.6089 | 1.66 | 1.62 | 1.65 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 117 | 16,598 | $ 1.62 | $ 26,958 | - | 1.08 - 26.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:06:54 | 10 | $ 1.68 | USD |
Sonnet BioTherapeutics Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.97M | 3.07M | - | 148k | -18.83M | -6.14 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Sonnet BioTherapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SONN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.88 | 1.88 | 1.49 | 1.60 | 56,411 | -0.26 | -13.83% |
| 1 Month | 1.78 | 1.97 | 1.49 | 1.71 | 26,740 | -0.16 | -8.99% |
| 3 Months | 1.88 | 2.3399 | 1.49 | 2.01 | 93,204 | -0.26 | -13.83% |
| 6 Months | 1.51 | 2.3399 | 1.30 | 1.86 | 73,943 | 0.11 | 7.28% |
| 1 Year | 10.2938 | 26.40 | 1.08 | 11.51 | 834,727 | -8.67 | -84.26% |
| 3 Years | 483.56 | 637.56 | 1.08 | 141.80 | 2,876,738 | -481.94 | -99.66% |
| 5 Years | 1,915.76 | 4,989.60 | 1.08 | 329.77 | 2,559,305 | -1,914.14 | -99.92% |
Sonnet BioTherapeutics Description
| Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. |
